tDCS for Catatonic Depression in Down Syndrome: A Pilot Study

NANot yet recruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 12, 2025

Primary Completion Date

August 1, 2027

Study Completion Date

September 30, 2027

Conditions
Down Syndrome
Interventions
DEVICE

Transcranial stimulation

A randomized, 2-arm, sham-controlled study, patients with Down syndrome presenting with major depressive episode (DSM5) with catatonic features will be randomly allocated to receive 15 sessions of either active (20 min, 2mA, ramp up/down 30 sec) or sham tDCS (20 min, ramp up/down 30 sec at the beginning and at the end of each stimulation session), thrice daily. Each stimulation session will be spaced at least two hours apart. The anode will be placed over the left DLPFC, the cathode over the right DLPFC using the Beam F3 algorithm in order to individualize target location based on head circumference, tragus to tragus and inion to nasion distances.

All Listed Sponsors
lead

Hôpital le Vinatier

OTHER

NCT06866925 - tDCS for Catatonic Depression in Down Syndrome: A Pilot Study | Biotech Hunter | Biotech Hunter